JP2019506396A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506396A5
JP2019506396A5 JP2018538137A JP2018538137A JP2019506396A5 JP 2019506396 A5 JP2019506396 A5 JP 2019506396A5 JP 2018538137 A JP2018538137 A JP 2018538137A JP 2018538137 A JP2018538137 A JP 2018538137A JP 2019506396 A5 JP2019506396 A5 JP 2019506396A5
Authority
JP
Japan
Prior art keywords
composition according
composition
cell
wound
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538137A
Other languages
English (en)
Japanese (ja)
Other versions
JP6918003B2 (ja
JP2019506396A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/017848 external-priority patent/WO2017127123A1/en
Publication of JP2019506396A publication Critical patent/JP2019506396A/ja
Publication of JP2019506396A5 publication Critical patent/JP2019506396A5/ja
Application granted granted Critical
Publication of JP6918003B2 publication Critical patent/JP6918003B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538137A 2016-01-21 2016-02-12 創傷治癒のための幹細胞 Expired - Fee Related JP6918003B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662281334P 2016-01-21 2016-01-21
US62/281,334 2016-01-21
PCT/US2016/017848 WO2017127123A1 (en) 2016-01-21 2016-02-12 Stem cells for wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020116882A Division JP2020172536A (ja) 2016-01-21 2020-07-07 創傷治癒のための幹細胞

Publications (3)

Publication Number Publication Date
JP2019506396A JP2019506396A (ja) 2019-03-07
JP2019506396A5 true JP2019506396A5 (https=) 2019-04-18
JP6918003B2 JP6918003B2 (ja) 2021-08-11

Family

ID=59360064

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018538137A Expired - Fee Related JP6918003B2 (ja) 2016-01-21 2016-02-12 創傷治癒のための幹細胞
JP2020116882A Withdrawn JP2020172536A (ja) 2016-01-21 2020-07-07 創傷治癒のための幹細胞
JP2022129977A Pending JP2022163207A (ja) 2016-01-21 2022-08-17 創傷治癒のための幹細胞

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020116882A Withdrawn JP2020172536A (ja) 2016-01-21 2020-07-07 創傷治癒のための幹細胞
JP2022129977A Pending JP2022163207A (ja) 2016-01-21 2022-08-17 創傷治癒のための幹細胞

Country Status (11)

Country Link
US (2) US10967006B2 (https=)
EP (1) EP3405566B1 (https=)
JP (3) JP6918003B2 (https=)
KR (1) KR20180102661A (https=)
CN (1) CN108884437A (https=)
AU (2) AU2016387339B2 (https=)
CA (1) CA3012330A1 (https=)
HK (1) HK1256413A1 (https=)
NZ (1) NZ745530A (https=)
SG (2) SG10201914102UA (https=)
WO (1) WO2017127123A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143415A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy
JP6666240B2 (ja) 2013-04-12 2020-03-13 フランチェスカ, サベリオ ラ 移植のための臓器の改良
KR20180102661A (ko) * 2016-01-21 2018-09-17 에이비티 홀딩 컴퍼니 상처 치유를 위한 줄기 세포
KR102188572B1 (ko) * 2017-09-25 2020-12-09 사회복지법인 삼성생명공익재단 뇌척수액을 포함하는 줄기세포 투여 제형 및 그의 제조방법
US20240245346A1 (en) * 2020-01-23 2024-07-25 Precision Healing, Inc. Image analysis using skin wound factors
US20220117491A1 (en) * 2020-01-23 2022-04-21 Precision Healing, Inc. Multispectral sample analysis using fluorescence signatures
US20240389931A1 (en) * 2020-01-23 2024-11-28 Precision Healing LLC Wound care diagnosis with fluorescence signatures
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
US12180456B2 (en) 2022-12-27 2024-12-31 AVITA Medical Americas, LLC Tissue healing
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Family Cites Families (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US7037721B1 (en) 1990-01-29 2006-05-02 Hy-Gene Biomedical, Inc. Protein-free defined media for the growth of normal human keratinocytes
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
AU2882992A (en) 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
WO1994000484A1 (en) 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5766951A (en) 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US6037174A (en) 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
GB9502022D0 (en) 1995-02-02 1995-03-22 Abuljadayel Ilham M S A method for preparing lymphohaematopoietic progenitor cells
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
US6653134B2 (en) 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
AU7984498A (en) 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
JP2002529071A (ja) 1998-11-09 2002-09-10 コンソルツィオ・ペール・ラ・ジェスティオーネ・デル・チェントロ・ディ・ビオテクノロジー・アヴァンツァテ 軟骨細胞様細胞のための無血清培地
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050169896A1 (en) 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US7838289B2 (en) 2001-02-14 2010-11-23 Abt Holding Company Assay utilizing multipotent adult stem cells
US7927587B2 (en) 1999-08-05 2011-04-19 Regents Of The University Of Minnesota MAPC administration for the treatment of lysosomal storage disorders
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
US8075881B2 (en) 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US8609412B2 (en) 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
EP2348104A1 (en) 1999-08-05 2011-07-27 Mcl Llc Multipotent adult stem cells and methods for isolation
WO2005113748A2 (en) 2004-04-21 2005-12-01 Regents Of The University Of Minnesota Mapc generation of lung tissue
EP1218489B1 (en) 1999-09-24 2009-03-18 Cybios LLC Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
EP2333049A1 (en) 1999-09-24 2011-06-15 ABT Holding Company Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US20010046489A1 (en) 1999-12-06 2001-11-29 Habener Joel E. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
ES2300320T3 (es) 2000-02-26 2008-06-16 Artecel, Inc. Celulas madre pluripotentes generadas a partir de celulas del estroma derivadas de tejido adiposo y sus usos.
AU2001284695A1 (en) 2000-07-31 2002-02-13 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7560280B2 (en) 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2305795B1 (en) 2000-12-06 2019-07-03 Celularity, Inc. Method of collecting placental stem cells
EP2316918B1 (en) 2001-02-14 2015-07-01 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US7056738B2 (en) 2001-03-23 2006-06-06 Tulane University Early stage multipotential stem cells in colonies of bone marrow stromal cells
KR100449141B1 (ko) 2001-04-19 2004-09-21 (주)라이프코드 간엽 간세포를 신경세포로 분화시키는 방법
DE60232585D1 (de) 2001-04-24 2009-07-23 Dolores Baksh Vorläuferzellpopulationen, deren expansion und die entstehung von nicht-hämatopoetischen zelltypen daraus
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
CA2473360A1 (en) 2002-01-25 2003-08-07 Genzyme Corporation Serum-free media for chondrocytes and methods of use thereof
US20060228798A1 (en) 2002-11-27 2006-10-12 Catherine Verfaillie Homologous recombination in multipotent adult progenitor cells
ATE482725T1 (de) 2003-04-01 2010-10-15 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
US20040235165A1 (en) 2003-05-19 2004-11-25 Darwin Prockop In vitro differentiation of adult stem cells
US8192348B2 (en) 2003-07-01 2012-06-05 Regents Of The University Of Minnesota Engineered blood vessels
US8426200B2 (en) 2003-07-02 2013-04-23 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
AU2004269409A1 (en) 2003-08-29 2005-03-10 Regents Of The University Of Minnesota Kidney derived stem cells and methods for their isolation, differentiation and use
US7794706B2 (en) 2003-10-14 2010-09-14 Medivas, Llc Bioactive wound dressings and implantable devices and methods of use
AU2004296848A1 (en) 2003-12-04 2005-06-23 Regents Of The University Of Minnesota Compositions and methods for the treatment of lysosomal storage disorders
EP1725656B1 (en) 2004-03-05 2013-10-02 John E. Davies Serum-free suspension culture system for mesenchymal progenitor cells
EP2298864B1 (en) 2004-03-22 2017-10-11 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
WO2006047743A2 (en) * 2004-10-26 2006-05-04 Regents Of The University Of Minnesota Swine multipotent adult progenitor cells
KR100593397B1 (ko) 2004-10-27 2006-06-28 한국원자력연구소 중배엽 줄기세포 및/또는 p 물질을 함유하는 상처 치유또는 상처 치유 촉진제, 또는 세포 치료제
EP2428563A1 (en) 2005-02-10 2012-03-14 Regents Of The University Of Minnesota Vascular/lymphatic endothelial cells
CN101218341A (zh) 2005-05-05 2008-07-09 明尼苏达大学董事会 Nk细胞抑制作用用于促进定植的mhc-i阴性细胞持续存在的用途
WO2006121454A2 (en) * 2005-05-05 2006-11-16 Regents Of The University Of Minnesota Use of mapc or progeny therefrom to populate lymphohematopoietic tissues
WO2007117262A2 (en) 2005-07-29 2007-10-18 Athersys, Inc. Culture of non-embryonic cells at high cell density
US20080194021A1 (en) 2005-07-29 2008-08-14 Mays Robert W Use of a Gsk-3 Inhibitor to Maintain Potency of Culture Cells
CN101310012B (zh) 2005-10-14 2012-05-09 明尼苏达大学董事会 非胚胎干细胞分化成具有胰腺表型的细胞
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
US20220118026A1 (en) 2005-11-09 2022-04-21 Abt Holding Company Mapc treatment of brain injuries and diseases
US8871198B2 (en) * 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US11992507B2 (en) 2006-01-23 2024-05-28 Abt Holding Company MAPC therapeutics without adjunctive immunosuppressive treatment
WO2008063675A2 (en) 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
WO2008154368A2 (en) 2007-06-08 2008-12-18 University Of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
EP2245141B1 (en) 2008-01-18 2018-03-14 Regents of the University of Minnesota Stem cell aggregates and methods for making and using
US20110070206A1 (en) 2008-02-29 2011-03-24 The Research Foundation Of State University Of New York Methods of applying physical stimuli to cells
EP2282746B8 (en) 2008-03-27 2015-12-09 Caladrius Biosciences, Inc. Compositions and methods using stem cells in cutaneous wound healing
CA2723765A1 (en) * 2008-05-08 2009-11-12 Coretherapix Slu Multipotent adult stem cell population
US9382514B2 (en) 2008-06-20 2016-07-05 Escape Therapeutics, Inc. Compositions comprising mesenchymal stem cell-derived fibroblasts
SG10201807935SA (en) 2008-09-04 2018-10-30 Abt Holding Co Use of stem cells to prevent neuronal dieback
US9057051B2 (en) 2008-10-31 2015-06-16 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte progenitor phenotypes, cells produced by the methods, and methods of using the cells
SG178064A1 (en) 2009-07-21 2012-03-29 Abt Holding Co Use of stem cells to reduce leukocyte extravasation
EP2456860B1 (en) 2009-07-21 2018-09-05 ABT Holding Company Use of stem cells to reduce leukocyte extravasation
JP2013510582A (ja) 2009-11-12 2013-03-28 ザ テキサス エーアンドエム ユニバーシティー システム 間葉幹細胞の球状集合体
US20130129686A1 (en) 2009-11-19 2013-05-23 Regents Of The University Reducing Inflammation Using Cell Therapy
US20150010610A1 (en) 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
WO2011106521A1 (en) 2010-02-25 2011-09-01 Abt Holding Company Modulation of macrophage activation
US20110206647A1 (en) 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis
WO2011106476A1 (en) 2010-02-25 2011-09-01 Abt Holding Company Modulation of microglia activation
CN102198156A (zh) 2010-03-26 2011-09-28 傅毓秀 用于治疗皮肤创伤之医药组合物
WO2011143415A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy
WO2011143411A1 (en) 2010-05-12 2011-11-17 Abt Holding Company Modulation of splenocytes in cell therapy for traumatic brain injury
US9090878B2 (en) 2010-06-17 2015-07-28 Katholieke Universiteit Leuven Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
WO2012009581A2 (en) 2010-07-14 2012-01-19 University Of Southern California Pharmaceutical compositions comprising gingiva-derived mesenchymal stem cells and methods of treating inflammation, wound healing and contact hypersensitivity
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
EP2609191B1 (en) 2010-08-24 2017-11-22 Regents Of The University Of Minnesota Non-static suspension culture of cell aggregates
EP2670842A2 (en) 2011-01-31 2013-12-11 Katholieke Universiteit Leuven KU Leuven Research & Development Methods for making cells with an extra-embryonic endodermal precursor phenotype
EP2718416B1 (en) 2011-06-06 2019-11-13 Regenesys bvba Expansion of stem cells in hollow fiber bioreactors
JP6666240B2 (ja) 2013-04-12 2020-03-13 フランチェスカ, サベリオ ラ 移植のための臓器の改良
DK2992088T3 (da) 2013-04-30 2019-11-11 Univ Leuven Kath Celleterapi for myelodysplastiske syndromer
EP3013944B1 (en) 2013-06-24 2020-03-18 University of Southern California Composition of mesenchymal stem cells
WO2015017772A1 (en) * 2013-08-01 2015-02-05 Parcell Laboratories, Llc Stem cell-based preparations and methods for dermal and connective tissue reconstruction and rejuvenation
US20160175485A1 (en) 2013-08-27 2016-06-23 The Regents Of The University Of California Combination therapy to promote wound healing
US20160069903A1 (en) 2014-09-10 2016-03-10 Fundació Institute De Ciències Foròniques Method for detecting cells
US20160326494A1 (en) 2015-05-05 2016-11-10 Katholieke Universiteit Leuven Methods for Pancreatic Islet Transplantation
WO2017062035A1 (en) 2015-10-09 2017-04-13 Abt Holding Company Methods for enhancing proliferation of t regulatory cells
KR20180102661A (ko) * 2016-01-21 2018-09-17 에이비티 홀딩 컴퍼니 상처 치유를 위한 줄기 세포
US20200246390A1 (en) 2019-02-01 2020-08-06 Abt Holding Company Multipotent adult projenitor cells for treatment of ich

Similar Documents

Publication Publication Date Title
JP2019506396A5 (https=)
Golchin et al. The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review
Trubiani et al. Periodontal ligament stem cells: current knowledge and future perspectives
Mazini et al. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs)
Duscher et al. Stem cells in wound healing: the future of regenerative medicine? A mini-review
Eom et al. Mesenchymal stem cell therapy for cirrhosis: present and future perspectives
Marx et al. Adipose-derived stem cells in veterinary medicine: characterization and therapeutic applications
Karantalis et al. Use of mesenchymal stem cells for therapy of cardiac disease
van de Ven et al. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration
Zou et al. Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs) potential role in healing cutaneous chronic wounds
De Francesco et al. Human adipose stem cells: from bench to bedside
Kuroda et al. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine
Mizuno et al. Concise review: adipose‐derived stem cells as a novel tool for future regenerative medicine
Marigo et al. The immunomodulatory properties of mesenchymal stem cells
Sharma et al. Translational products of adipose tissue-derived mesenchymal stem cells: Bench to bedside applications
Conese et al. The Role of Adipose‐Derived Stem Cells, Dermal Regenerative Templates, and Platelet‐Rich Plasma in Tissue Engineering‐Based Treatments of Chronic Skin Wounds
Yang et al. Potential application of adipose-derived stem cells and their secretory factors to skin: discussion from both clinical and industrial viewpoints
Lim et al. Epithelial and mesenchymal stem cells from the umbilical cord lining membrane
Oh et al. Transplantation of an adipose stem cell cluster in a spinal cord injury
Li et al. Mesenchymal stem cell–based therapy for nonhealing wounds: today and tomorrow
Lewis Stem cell application in acute burn care and reconstruction
Cerqueira et al. Using stem cells in skin regeneration: possibilities and reality
Kikuchi-Taura et al. Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells
Hu et al. In vitro and in vivo hepatic differentiation of adult somatic stem cells and extraembryonic stem cells for treating end stage liver diseases
Mahjour et al. Hair follicle regeneration in skin grafts: current concepts and future perspectives